Is MeiraGTx Holdings PLC (MGTX) overvalued? · rev $33.3M
MeiraGTx Holdings PLC (MGTX) is a biotechnology company listed on US.
This page asks whether MeiraGTx Holdings PLC (MGTX) looks expensive on cached numbers — not a short thesis.
Latest reported MGTX revenue for 2024-12-31 was $33.3M. Net income was -$147.8M. Revenue was up 137.4% from 2023-12-31 to 2024-12-31. MGTX currently screens at market cap $532.8M.
MGTX currently screens at market cap $532.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MGTX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MGTX stock page for the full model, not this heading.
Not investment advice.